Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

Phase II randomized, double-blind, placebo-controlled 3x3 factorial trial evaluating the antihypertensive efficacy and safety of combining fimasartan with amlod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension | Phase 2 | Status: COMPLETED